An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies

Pharmacology and Therapeutics

Volumn 141, Issue 3, 2014, Pages 347-357

  Musumeci, Domenica ^a   Roviello, Giovanni N ^b   Montesarchio, Daniela ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

DNA based inhibitors; HMGB1; HMGB1 receptors; Peptide protein inhibitors; Small molecule inhibitors

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CURVED DNA; GABEXATE MESILATE; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP INHIBITOR; OLIGONUCLEOTIDE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; COMPETITIVE INHIBITION; DRUG IDENTIFICATION; DRUG INTERACTION; DRUG TARGETING; HUMAN; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; REVIEW;

DNA-BASED INHIBITORS; EP; ETHYL PYRUVATE; GL; GLYCYRRHIZIN; HIGH-MOBILITY GROUP BOX; HMGB; HMGB1; HMGB1-RECEPTORS; I/R; IL; INTERLEUKIN; ISCHEMIA-REPERFUSION; LIPOPOLYSACCHARIDE; LPS; ODN; OLIGODEOXYRIBONUCLEOTIDE; PEPTIDE NUCLEIC ACID; PEPTIDE/PROTEIN INHIBITORS; PNA; RAGE; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS; SMALL-MOLECULE INHIBITORS; TLR; TNF; TOLL-LIKE RECEPTOR; TUMOR NECROSIS FACTOR;

ANIMALS; AUTOIMMUNE DISEASES; DRUG DESIGN; HMGB1 PROTEIN; HUMANS; INFLAMMATION; MOLECULAR TARGETED THERAPY; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 84892171140     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2013.11.001     Document Type: Review

References (136)

1. E. Abraham, A. Anzueto, G. Gutierrez, S. Tessler, G. San Pedro, and R. Wunderink et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock Lancet 351 1998 929 933
2. U. Andersson, H. Erlandsson-Harris, H. Yang, and K.J. Tracey HMGB1 as a DNA-binding cytokine J Leukoc Biol 72 2002 1084 1091
3. U. Andersson, and H.E. Harris The role of HMGB1 in the pathogenesis of rheumatic disease Biochim Biophys Acta 1799 2010 141 148
4. U. Andersson, H. Wang, K. Palmblad, A.C. Aveberger, O. Bloom, and H. Erlandsson-Harris et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes J Exp Med 192 2000 565 570
5. D.C. Angus, L. Yang, L. Kong, J.A. Kellum, R.L. Delude, and K.J. Tracey et al. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis Crit Care Med 35 2007 1061 1067
6. T. Arumugam, V. Ramachandran, S.B. Gomez, A.M. Schmidt, and C.D. Logsdon S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis Clin Cancer Res 18 2012 4356 4364
7. B. Beutler, and G.E. Grau Tumor necrosis factor in the pathogenesis of infectious diseases Crit Care Med 21 1993 S423 S435
8. M.E. Bianchi, and M. Beltrame Upwardly mobile proteins. The role of HMG proteins in chromatine structure, gene expression and neoplasia EMBO Rep 1 2000 109 119
9. M.E. Bianchi, M. Beltrame, and G. Pavonessa Specific recognition of cruciform DNA by nuclear protein HMG1 Science 243 1989 1056 1059
10. A. Bierhaus, P.M. Humpert, M. Morcos, T. Wendt, T. Chavakis, and B. Arnold et al. Understanding RAGE, the receptor for advanced glycation end products J Mol Med 83 2005 876 886
11. T. Bonaldi, G. Langst, R. Strohner, P.B. Becker, and M.E. Bianchi The DNA chaperone HMGB1 facilitates ACF/CHRAC dependent nucleosome sliding EMBO J 21 2002 6865 6873
12. T. Bonaldi, F. Talamo, P. Scaffidi, D. Ferrera, A. Porto, and A. Bachi et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion EMBO J 22 2003 5551 5560
13. V. Borsi, L. Cerofolini, M. Fragai, and C. Luchinat NMR characterization of the C-terminal tail of full-length RAGE in a membrane mimicking environment J Biomol NMR 54 2012 285 290
14. J. Brett, A.M. Schmidt, S.D. Yan, Y.S. Zou, E. Weidman, and D. Pinsky et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues Am J Pathol 143 1993 1699 1712
15. A. Bruchfeld, A.R. Qureshi, B. Lindholm, P. Barany, L. Yang, and P. Stenvinkel et al. Mol Med 14 2008 109 115
16. E.M. Bucci, M. Valente, D. Musumeci, R. Sapio, V. Anrò, and G.N. Roviello et al. ODN-based drugs for targeting of extracellular proteins Nucleosides Nucleotides Nucleic Acids 26 2007 1047 1050
17. M. Bustin Regulation of DNA-dependent activities by the functional motifs of the high mobility group chromosomal proteins Mol Cell Biol 19 1999 5237 5246
18. M. Bustin, D.A. Lehn, and D. Landsman Structural features of the HMG chromosomal proteins and their genes Biochim Biophys Acta 1049 1990 231 243
19. A. Chorny, and M. Delgado Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1 Am J Pathol 172 2008 1297 1307
20. B.M. Dattilo, G. Fritz, E. Leclerc, C.W. Kooi, C.W. Heizmann, and W.J. Chazin The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units Biochemistry 46 2007 6957 6970
21. S.H. Davé, J.S. Tilstra, K. Matsuoka, F. Li, R.A. DeMarco, and D. Beer-Stolz et al. Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis J Leukoc Biol 86 2009 633 643
22. L. De Napoli, G. Di Fabio, A. Messere, D. Montesarchio, D. Musumeci, and G. Piccialli Synthesis and characterization of new 3′-3′ linked oligodeoxyribonucleotides for alternate strand triple helix formation Tetrahedron 55 1999 9899 9914
23. L. De Napoli, A. Messere, D. Montesarchio, A. Pepe, G. Piccialli, and M. Varra Synthesis and triple-helix formation by alternate strand recognition of oligonucleotides containing 3′-3′-phosphodiester bonds J Org Chem 62 1997 9024 9030
24. B. Degryse, T. Bonaldi, P. Scaffidi, S. Müller, M. Resnati, and F. Sancito et al. The High Mobility Group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells J Cell Biol 152 2001 1197 2006
25. D. Du, J. Yan, J. Ren, H. Lv, Y. Li, and S. Xu et al. Synthesis, biological evaluation, and molecular modeling of glycyrrhizin derivatives as potent high-mobility group box-1 inhibitors with anti-heart-failure activity in vivo J Med Chem 56 2013 97 108
26. I. Dumitriu, and P. Baruah Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products J Immunol 174 2005 7506 7515
27. J.E. Ellerman, C.K. Brown, M. De Vera, H.J. Zeh, T. Billiar, and A. Rubarteli et al. Masquerader: High mobility group box-1 and cancer Clin Cancer Res 13 2007 2836 2848
28. S. Gardella, C. Andrei, D. Ferrera, and L. Lotti The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway EMBO Rep 3 2002 995 1001
29. R.S. Goldstein, A. Bruchfeld, L. Yang, A.R. Qureshi, M. Gallowitsch-Puerta, and N.B. Patel et al. Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis Mol Med 13 2007 210 215
30. Q. Gong, J.-F. Xu, H. Yin, S.-F. Liu, L.-H. Duan, and Z.-L. Bian Protective effect of antagonist of high-mobility group box 1 on lipopolysaccharide-induced acute lung injury in mice Scand J Immunol 69 2009 29 35
31. G. Gong, L.B. Yuan, L. Hu, W. Wu, L. Yin, and J.L. Hou et al. Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1 Acta Pharmacol Sin 33 2012 11 18
32. W. Gong, Y. Zheng, F. Chao, Y. Li, Z. Xu, and G. Huang et al. The anti-inflammatory activity of HMGB1 A box is enhanced when fused with C-terminal acidic tail J Biomed Biotechnol 2010 2010 915234
33. G. Goodwin, and E. Johns The isolation and purification of the high mobility group (HMG) nonhistone chromosomal proteins Methods Cell Biol 16 1977 257 267
34. G.H. Goodwin, C. Sanders, and E.W. Johns A new group of chromatin-associated proteins with a high content of acidic and basic amino acids Eur J Biochem 38 1973 14 19
35. M.-L. Gougeon, and M. Bras Natural killer cells, dendritic cells, and the alarmin high-mobility group box 1 protein: A dangerous trio in HIV-1 infection? Curr Opin HIV AIDS 6 2011 364 372
36. G.Y. Gwak, T.G. Moon, D.H. Lee, and B.C. Yoo Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway World J Gastroenterol 18 2012 679 684
37. S. Hagiwara, H. Iwasaka, S. Matsumoto, A. Hasegawa, N. Yasuda, and T. Noguchi In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models Shock 33 2010 282 288
38. S. Hagiwara, H. Iwasaka, and T. Noguchi Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury J Anesth 21 2007 164 170
39. S. Hagiwara, H. Iwasaka, K. Togo, and T. Noguchi A neutrophil elastase inhibitor, sivelestat, reduces lung injury following endotoxin-induced shock in rats by inhibiting HMGB1 Inflammation 31 2008 227 234
40. S.H. Han, Y.H. Kim, and I. Mook-Jung RAGE: The beneficial and deleterious effects by diverse mechanisms of actions Mol Cells 31 2011 91 97
41. C.H. Hardaman, R.W. Broadhurst, A.R.C. Rain, K.D. Grasser, J.O. Thomas, and E.D. Laue Structure of the A-domain of HMG1 and its interaction with DNA as studied by heteronuclear three and four dimensional NMR spectroscopy Biochemistry 34 1995 16596 16607
42. S. Hidaka, H. Iwasaka, S. Hagiwara, and T. Noguchi Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury J Surg Res 165 2011 142 150
43. H.J. Huttunen, C. Fages, and H. Rauvala Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways J Biol Chem 274 1999 19919 19924
44. I. Ito, J. Fukazawa, and M. Yoshida Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils J Biol Chem 282 2007 16336 16344
45. W. Jiang, and D.S. Pisetsky Ann Rheum Dis 67 2008 727 728
46. S.W. Kim, Y. Jin, J.H. Shin, I.D. Kim, H.K. Lee, and S. Park et al. Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion Neurobiol Dis 46 2012 147 156
47. J.B. Kim, J. Sig Choi, Y.M. Yu, K. Nam, C.S. Piao, and S.W. Kim et al. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain J Neurosci 26 2006 6413 6421
48. M. Koch, S. Chitayat, B.M. Dattilo, A. Schiefner, J. Diez, and W.J. Chazin et al. Structural basis for ligand recognition and activation of RAGE Structure 18 2010 1342 1352
49. R. Kokkola, A. Andersson, G. Mullins, T. Ostberg, C.J. Treutiger, and B. Arnold et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages Scand J Immunol 61 2005 1 9
50. R. Kokkola, J. Li, E. Sundberg, A.C. Aveberger, K. Palmblad, and H. Yang et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity Arthritis Rheum 48 2003 2052 2058
51. C. Koulis, J.B. de Haan, and T.J. Allen Novel pathways and therapies in experimental diabetic atherosclerosis Expert Rev Cardiovasc Ther 10 2012 323 335
52. Y. Kuroiwa, Y. Takakusagi, T. Kusayanagi, K. Kuramochi, T. Imai, and T. Hirayama et al. Identification and characterization of the direct interaction between methotrexate (MTX) and high-mobility group box 1 (HMGB1) protein PLoS One 8 2013 e63073
53. W. Lee, S.K. Ku, J.W. Bae, and J.S. Bae Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models Food Chem Toxicol 50 2012 1826 1833
54. W. Li, M. Ashok, J. Li, H. Yang, A.E. Sama, and H. Wang A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1 PLoS One 2 2007 e1153
55. J. Li, R. Kokkola, S. Tabibzadeh, R. Yang, M. Oceani, and X. Qiang et al. Structural basis for the proinflammatory cytokine activity of high mobility group box 1 Mol Med 9 2003 37 45
56. W. Li, J. Li, M. Ashok, R. Wu, D. Chen, and L. Yang et al. A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1 J Immunol 178 2007 3856 3864
57. W. Li, J. Li, A.E. Sama, and H. Wang Carbenoxolone blocks endotoxin-induced PKR activation and HMGB1 release Mol Med 19 2013 203 211
58. G. Li, X. Liang, and M.T. Lotze HMGB1: The central cytokine for all lymphoid cells Front Immunol 4 2013 68
59. J. Li, X. Qu, and A.M. Schmidt Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells J Biol Chem 273 1998 30870 30878
60. W. Li, A.E. Sama, and H. Wang Role of HMGB1 in cardiovascular diseases Curr Opin Pharmacol 6 2006 130 135
61. J. Li, and A.M. Schmidt Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products J Biol Chem 272 1997 498 506
62. M.L. Li, X.F. Wang, Z.J. Tan, P. Dong, J. Gu, and J.H. Lu et al. Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis Int J Immunopathol Pharmacol 25 2012 955 965
63. J. Li, H. Xie, T. Wen, H. Liu, W. Zhu, and X. Chen Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus J Rheumatol 37 2010 766 775
64. B. Liliensiek, M.A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper, and S. Hofer et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J Clin Invest 113 2004 1641 1650
65. M. Liu, Y. Yu, H. Jiang, L. Zhang, P.P. Zhang, and P. Yu et al. Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis Acta Pharmacol Sin 34 2013 830 836
66. C.D. Logsdon, M.K. Fuentes, E.H. Huang, and T. Arumugam RAGE and RAGE ligands in cancer Curr Mol Med 7 2007 777 789
67. E.C. Lutterloh, S.M. Opal, D.D. Pittman, J.C. Keith Jr., X.Y. Tan, and B.M. Clancy et al. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection Crit Care 11 2007 R122
68. R. Mencucci, E. Favuzza, and U. Meschini Assessment of the tolerability profile of an ophthalmic solution of 5% glycyrrhizin and copolymer PEG/PPG on and evaluation of its efficacy in the treatment of moderate to severe blepharitis Clin Ophtalmol 7 2013 1403 1410
69. G. Milano, D. Musumeci, M. Gaglione, and A. Messere An alternative strategy to synthesize PNA and DNA magnetic conjugates forming nanoparticle assembly based on PNA/DNA duplexes Mol BioSyst 6 2010 553 561
70. L. Moggio, L. De Napoli, B. Di Blasio, G. Di Fabio, J. D'Onofrio, and D. Montesarchio et al. Solid-phase synthesis of cyclic PNA and PNA-DNA chimeras Org Lett 8 2006 2015 2018
71. L. Mollica, F. De Marchis, A. Spitaleri, C. Dalla Costa, D. Pennacchini, and M. Zamai et al. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities Chem Biol 14 2007 431 441
72. M.I. Mosevitsky, V.A. Novitskaya, M.G. Iogannsen, and M.A. Zabezhinsky Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions Eur J Biochem 185 1989 303 310
73. S. Müller, P. Scaffidi, B. Degryse, T. Bonaldi, L. Ronfani, and A. Agresti et al. New EMBO members' review: The double life of HMGB1 chromatin protein: Architectural factor and extracellular signal EMBO J 20 2001 4337 4340
74. D. Musumeci, E.M. Bucci, G.N. Roviello, R. Sapio, M. Valente, and M. Moccia et al. DNA-based strategies for blocking HMGB1 cytokine activity: Design, synthesis and preliminary in vitro/in vivo assays of DNA and DNA-like duplexes Mol BioSyst 7 2011 1742 1752
75. D. Musumeci, and D. Montesarchio Polyvalent nucleic acid aptamers and modulation of their activity: A focus on the thrombin binding aptamer Pharmacol Ther 136 2012 202 215
76. D. Musumeci, G. Oliviero, G.N. Roviello, E.M. Bucci, and G. Piccialli G-quadruplex-forming oligonucleotide conjugated to magnetic nanoparticles: synthesis, characterization, and enzymatic stability assays Bioconjug Chem 23 2012 382 391
77. D. Musumeci, G.N. Roviello, D. Montesarchio, R. Sapio, M. Valente, and V. Anrò et al. Hairpin ODN-based ligands as potential inhibitors of HMGB1 cytokine activity RSC Adv 3 2013 12176 12184
78. M. Nagato, K. Okamoto, Y. Abe, A. Higure, and K. Yamaguchi Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia Crit Care Med 37 2009 2181 2186
79. J.A. Nogueira-Machado, C.M. Volpe, C.A. Veloso, and M.M. Chaves HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation Expert Opin Ther Targets 15 2011 1023 1035
80. M. Ogiku, H. Kono, M. Hara, M. Tsuchiya, and H. Fujii Glycyrrhizin prevents liver injury by inhibition of high-mobility group box 1 production by Kupffer cells after ischemia-reperfusion in rats J Pharmacol Exp Ther 339 2011 93 98
81. M. Ohnishi, H. Katsuki, C. Fukutomi, M. Takahashi, M. Motomura, and M. Fukunaga et al. HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats Neuropharmacology 61 2011 975 980
82. G. Oliviero, N. Borbone, A. Galeone, M. Varra, G. Piccialli, and L. Mayol Synthesis and characterization of a bunchy oligonucleotide forming a monomolecular parallel quadruplex structure in solution Tetrahedron Lett 45 2004 4869 4872
83. S.A. Onate, P. Prendergast, J.P. Wagner, M. Nissen, R. Reeves, and D.E. Pettijhon et al. The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences Mol Cell Biol 14 1994 3375 3391
84. T. Ostendorp, E. Leclerc, A. Galichet, M. Koch, N. Demling, and B. Weigle et al. Structural and functional insights into RAGE activation by multimeric S100B EMBO J 26 2007 3868 3878
85. R. Palumbo, F. De Marchis, T. Posterla, A. Conti, M. Alessio, and M.E. Bianchi Src family kinases are necessary for cell migration induced by extracellular HMGB1 J Leukoc Biol 86 2009 617 623
86. R. Palumbo, B.G. Galvez, T. Pusterla, F. De Marchis, G. Cossu, and K.B. Marcu et al. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-κB activation J Cell Biol 179 2007 33 40
87. R. Palumbo, M. Sampaolesi, F. De Marchis, R. Tonlorenzi, S. Colombetti, and A. Mondino et al. J Cell Biol 164 2004 441 449
88. H. Park, F.G. Adsit, and J.C. Boyington The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding J Biol Chem 285 2010 40762 40770
89. E.A. Pasheva, I.G. Pashev, and A. Favre Preferential binding of high mobility group 1 protein to UV-damaged DNA. Role of the COOH-terminal domain J Biol Chem 273 1998 24730 24736
90. T. Paull, M.J. Hakynson, and R.C. Johnson The nonspecific DNA-binding and bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures Genes Dev 7 1993 1521 1534
91. P.M. Pil, and S.J. Lippard Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin Science 256 1992 234 237
92. D.S. Pisetsky, H. Erlandsson-Harris, and U. Andersson High-mobility group box protein 1 (HMGB1): An alarmin mediating the pathogenesis of rheumatic disease Arthritis Res Ther 10 2008 209
93. C.M. Read, P.D. Cary, C. Crane-Robinson, P.C. Driscoll, and D.G. Norman Solution structure of a DNA-binding domain from HMG1 Nucleic Acids Res 21 1993 3427 3436
94. N.C. Riedemann, R.F. Quo, and P.A. Ward The enigma of sepsis J Clin Invest 112 2003 460 467
95. L. Ronfani, M. Ferraguti, L. Croci, C.E. Ovitt, H.R. Scholer, and G.G. Consalez et al. Reduced fertility and spermatogenesis defects in mice lacking chromosomal protein HMGB2 Development 128 2001 1265 1273
96. Z. Sárkány, T.P. Ikonen, F. Ferreira-da-Silva, M.J. Saraiva, D. Svergun, and A.M. Damas Solution structure of the soluble receptor for advanced glycation end products (sRAGE) J Biol Chem 286 2011 37525 37534
97. P. Scaffidi, T. Misteli, and M.E. Bianchi Release of chromatin protein HMGB1 by necrotic cell triggers inflammation Nature 418 2002 191 195
98. H. Schierbeck, P. Lundbäck, K. Palmblad, L. Klevenvall, H. Erlandsson-Harris, and U. Andersson et al. Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models Mol Med 17 2011 1039 1044
99. M. Schiraldi, A. Rauchi, L.M. Muñoz, E. Livoti, B. Celona, and E. Venereau et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 J Exp Med 209 2012 551 563
100. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J Clin Invest 108 2001 949 955
101. C. Semino, G. Angelini, A. Poggi, and A. Rubartelli NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1 Blood 106 2005 609 616
102. R. Smolarczyk, T. Cichoń, S. Matuszczak, I. Mitrus, M. Lesiak, and M. Kobusińska et al. The role of Glycyrrhizin, an inhibitor of HMGB1 protein, in anticancer therapy Arch Immunol Ther Exp (Warsz) 60 2012 391 399
103. L.J. Sparvero, D. Asafu-Adjei, R. Kang, D. Tang, N. Amin, and J. Im et al. RAGE (receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation J Transl Med 7 2009 17
104. J. Sunden-Cullberg, A. Norrby-Teglund, A. Rouhiainen, H. Rauvala, G. Herman, and K.J. Tracey et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock Crit Care Med 33 2005 564 573
105. K. Takata, T. Takada, A. Ito, M. Asai, M. Tawa, and Y. Saito et al. Microglial amyloid-β1-40 phagocytosis dysfunction is caused by high-mobility group box protein-1: implications for the pathological progression of Alzheimer's disease Int J Alzheimers Dis 2012 2012 685 739
106. D. Tang, R. Kang, K.M. Livesey, C.-W. Cheh, A. Farkas, and P. Loughran et al. Endogenous HMGB1 regulates autophagy J Cell Biol 190 2010 881 892
107. D. Tang, R. Kang, W. Xiao, H. Zhang, M.T. Lotze, and H. Wang et al. Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function Am J Respir Cell Mol Biol 41 2009 651 660
108. D. Tang, R. Kang, H.J. Zeh III, and M.T. Lotze High-mobility group box 1 and cancer Biochim Biophys Acta 1799 2010 131 140
109. D. Tang, and M.T. Lotze Tumor immunity times out: TIM-3 and HMGB1 Nat Immunol 13 2012 808 810
110. Y. Tang, B. Lv, H. Wang, X. Xiao, and X. Zuo PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia Int Immunopharmacol 8 2008 1646 1651
111. D. Tang, Y. Shi, R. Kang, T. Li, W. Xiao, and H. Wang et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1 J Leukoc Biol 81 2007 741 747
112. J.O. Thomas HMG1 and 2: Architectural DNA-binding proteins Biochem Soc Trans 29 2001 395 401
113. J. Todorova, and E. Pasheva High mobility group B1 protein interacts with its receptor RAGE in tumor cells but not in normal tissues Oncol Lett 3 2012 214 218
114. D. Topalova, I. Ugrinova, I.G. Pashev, and E.A. Pasceva HMGB1 protein inhibits DNA replication in vitro: A role of the acetylation and the acidic tail Int J Biochem Cell Biol 40 2008 1536 1542
115. I. Ugrinova, I.G. Pashev, and E.A. Pasceva Nucleosome binding properties and co-remodeling activities of native and in vivo acetylated HMGB-1 and HMGB-2 proteins Biochemistry 48 2009 6502 6507
116. I. Ugrinova, S. Zlateva, I.G. Pashev, and E.A. Pasceva Native HMGB1 protein inhibits repair of cisplatin-damaged nucleosomes in vitro Int J Biochem Cell Biol 41 2009 1556 1562
117. V. Urbonaviciute, and R.E. Voll High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus J Intern Med 270 2011 309 318
118. E. Venereau, M. Schiraldi, M. Uguccioni, and M.E. Bianchi HMGB1 and leukocyte migration during trauma and sterile inflammation Mol Immunol 55 2013 76 82
119. R. Vitali, F. Palone, S. Cucchiara, A. Neuroni, L. Cavone, and M. Costanzo et al. Dipotassium glycyrrhizate inhibits HMGB1-dependent inflammation and ameliorates colitis in mice PLoS One 8 2013 e66527
120. R.E. Voll, V. Urbonaviciute, B. Furnrohr, M. Herrmann, and J.R. Kalden The role of high-mobility group box 1 protein in the pathogenesis of autoimmune diseases Curr Rheumatol Rep 10 2008 341 342
121. J.M. Walker, K. Gooderham, J.R. Hastings, E. Mayes, and E.W. Johns The primary structures of non-histone chromosomal proteins HMG1 and 2 FEBS Lett 122 1980 264 270
122. H. Wang, O. Bloom, M. Zhang, J.M. Vishnubhakat, M. Ombrellino, and J. Che et al. HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248 251
123. H. Wang, H. Yang, and K.J. Tracey Extracellular role of HMGB1 in inflammation and sepsis J Intern Med 255 2004 320 331
124. Q. Wang, M. Zeng, W. Wang, and J. Tang The HMGB1 acidic tail regulates HMGB1 DNA binding specificity by a unique mechanism Biochem Biophys Res Commun 360 2007 14 19
125. L. Wang, X. Zhang, L. Liu, R. Yang, L. Cui, and M. Li Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kB expression Neurosci Lett 471 2010 152 156
126. W. Wang, F. Zhao, Y. Fang, X. Li, L. Shen, and T. Cao et al. Glycyrrhizin protects against porcine endotoxemia through modulation of systemic inflammatory response Crit Care 17 2013 R44
127. H.M. Weir, P.J. Kraulis, C.S. Hill, A.R.C. Raine, E.D. Laue, and J.O. Thomas Structure of the HMG box motif in the B-domain of HMG1 EMBO J 12 1993 1311 1319
128. H. Yang, D.J. Antoine, U. Andersson, and K.J. Tracey The many faces of HMGB1: Molecular structure-functional activity in inflammation, apoptosis, and chemotaxis J Leukoc Biol 93 2013 865 873
129. R. Yang, T. Harada, K.P. Mollen, J.M. Prince, R.M. Levy, and J.A. Englert et al. Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock Mol Med 12 2006 105 114
130. H. Yang, M. Oceani, J. Li, X. Qiang, M. Tanovic, and H.E. Harris et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proc Natl Acad Sci U S A 1 2004 296 301
131. W.V. Yotov, and R. St-Arnaud Nucleotide sequence of a mouse cDNA encoding the nonhistonne chromosomal high mobility group protein-1 (HMG1) Nucleic Acids Res 20 1992 3516
132. J.H. Youn, and J.S. Shin Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion J Immunol 177 2006 7889 7897
133. C.L. Zhai, M.Q. Zhang, Y. Zhang, H.X. Xu, J.M. Wang, and G.P. An et al. Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway Acta Pharmacol Sin 33 2012 1477 1487
134. Y. Zhang, W. Li, S. Zhu, A. Jundoria, J. Li, and H. Yang et al. Tanshinone IIA sodium sulfonate facilitates endocytic HMGB1 uptake Biochem Pharmacol 84 2012 1492 1500
135. J. Zhang, J.S. Zhu, Z. Zhou, W.X. Chen, and N.W. Chen Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo Oncol Rep 27 2012 1511 1519
136. A. Zickert, K. Palmblad, B. Sundelin, S. Chavan, K.J. Tracey, and A. Bruchfeld et al. Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis Arthritis Res Ther 14 2012 R36